'Hijacker' drives cancer in some patients with high-risk neuroblastoma
- OPACC
- Jan 24, 2018
- 1 min read
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights may help scientists develop more effective therapies, including precision medicines.
Read more: https://medicalxpress.com/news/2018-01-hijacker-cancer-patients-high-risk-neuroblastoma.html
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments